BriaCell Therapeutics Corp. (BCTX)
BCTX Stock Price Chart
Explore BriaCell Therapeutics Corp. interactive price chart. Choose custom timeframes to analyze BCTX price movements and trends.
BCTX Company Profile
Discover essential business fundamentals and corporate details for BriaCell Therapeutics Corp. (BCTX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
14 Mar 2012
Employees
16.00
Website
https://www.briacell.comCEO
William V. Williams FCPA,
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and development agreement with the National Cancer Institute for developing Bria-OTS, a personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.
BCTX Financial Timeline
Browse a chronological timeline of BriaCell Therapeutics Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Mar 2026
Upcoming earnings on 27 Oct 2025
EPS estimate is -$1.39.
Upcoming earnings on 27 Oct 2025
EPS estimate is -$12.11.
Stock split effective on 25 Aug 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 Jun 2025
EPS came in at -$16.40 surpassing the estimated -$17.60 by +6.82%.
Earnings released on 12 Mar 2025
EPS came in at -$23.30 falling short of the estimated -$19.40 by -20.10%.
Stock split effective on 29 Jan 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 16 Dec 2024
EPS came in at -$32.98 falling short of the estimated -$0.30 by -10.89K%.
Earnings released on 31 Jul 2024
EPS came in at -$0.73 .
Earnings released on 14 Jun 2024
EPS came in at $16.49 surpassing the estimated -$82.46 by +120.00%.
Earnings released on 18 Mar 2024
EPS came in at -$106.45 falling short of the estimated -$29.99 by -254.95%.
Earnings released on 14 Dec 2023
EPS came in at -$74.96 falling short of the estimated -$26.99 by -177.73%.
Earnings released on 31 Jul 2023
EPS came in at -$1.70 .
Earnings released on 14 Jun 2023
EPS came in at -$47.98 surpassing the estimated -$53.97 by +11.10%.
Earnings released on 15 Mar 2023
EPS came in at -$115.44 falling short of the estimated -$55.47 by -108.11%.
Earnings released on 14 Dec 2022
EPS came in at -$10.49 surpassing the estimated -$49.48 by +78.80%.
Earnings released on 5 Jul 2022
EPS came in at -$0.43 falling short of the estimated -$0.19 by -128.46%.
Earnings released on 13 Jun 2022
EPS came in at -$47.98 falling short of the estimated -$28.49 by -68.41%.
Earnings released on 15 Mar 2022
EPS came in at -$35.98 falling short of the estimated -$25.49 by -41.15%.
Earnings released on 14 Dec 2021
EPS came in at -$22.49 .
Earnings released on 31 Jul 2021
EPS came in at -$2.74K .
Earnings released on 29 Jun 2021
EPS came in at -$139.43 .
Earnings released on 31 Mar 2021
EPS came in at -$61.47 .
Earnings released on 31 Oct 2020
EPS came in at $3.41 .
BCTX Stock Performance
Access detailed BCTX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.